Year 3

Since the previous report, efforts have focused on expanding the stem cell-protective hydrogel technology to other biomaterial formulations to confirm the broad applicability of this technology and to optimize the technology for specific disease and injury therapies.

During the past year, three manuscripts were accepted for publication, and an additional three manuscripts are in preparation. The technology has been protected by the Stanford Office of Technology Licensing with a patent disclosure to the US Patent Office.